Back to Search
Start Over
1482: IMPACT OF OBESITY ON MORTALITY IN PATIENTS WITH SEPTIC SOCK RECEIVING FIXED-DOSE VASOPRESSIN.
- Source :
-
Critical Care Medicine . 2022 Supplement, Vol. 50, p744-744. 1p. - Publication Year :
- 2022
-
Abstract
- B Introduction: b The Surviving Sepsis Guidelines recommend initiating fixed-dose vasopressin (AVP) for patients with persistent hypotension despite norepinephrine (NE), but it is unclear if this dosing strategy is sufficient in obese patients. B Methods: b An interim analysis of a multicenter, retrospective cohort study was conducted to assess the impact of fixed-dose AVP (0.03 or 0.04 units/min) on mortality in obese patients with septic shock compared to non-obese patients. B Conclusions: b Compared to non-obese patients, obese patients with septic shock receiving fixed-dose AVP had a higher incidence of mortality. [Extracted from the article]
- Subjects :
- *VASOPRESSIN
*OBESITY
*MYOCARDIAL infarction
*MORTALITY
Subjects
Details
- Language :
- English
- ISSN :
- 00903493
- Volume :
- 50
- Database :
- Academic Search Index
- Journal :
- Critical Care Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 154198187
- Full Text :
- https://doi.org/10.1097/01.ccm.0000812252.11331.cb